• Molecular NameDeslanoside
  • SynonymNA
  • Weight943.09
  • Drugbank_IDDB01078
  • ACS_NO17598-65-1
  • Show 3D model
  • LogP (experiment)0.16
  • LogP (predicted, AB/LogP v2.0)-0.3
  • pkaN/A
  • LogD (pH=7, predicted)-0.3
  • Solubility (experiment)0.2 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.06
  • LogSw (predicted, AB/LogsW2.0)0.25
  • Sw (mg/ml) (predicted, ACD/Labs)0.82
  • No.of HBond Donors9
  • No.of HBond Acceptors19
  • No.of Rotatable Bonds10
  • TPSA282.21
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA cardiac glycoside from the leaves of Digitalis lanata.
  • Absorption_valueN/A
  • Absorption (description)Incompletely absorbed after oral administration
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)Plasma:whole blood ratio, 1.4.
  • MetabollsmN/A
  • Half life33 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include ventricular tachycardia, ventricular fibrillation, progressive bradyarrhythmias, or heart block.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A